213 related articles for article (PubMed ID: 36289122)
1. Isoflavone consumption reduces inflammation through modulation of phenylalanine and lipid metabolism.
Shrode RL; Cady N; Jensen SN; Borcherding N; Mangalam AK
Metabolomics; 2022 Oct; 18(11):84. PubMed ID: 36289122
[TBL] [Abstract][Full Text] [Related]
2. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones.
Guadamuro L; Dohrmann AB; Tebbe CC; Mayo B; Delgado S
BMC Microbiol; 2017 Apr; 17(1):93. PubMed ID: 28415978
[TBL] [Abstract][Full Text] [Related]
3. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
[TBL] [Abstract][Full Text] [Related]
4. Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis.
Jensen SN; Cady NM; Shahi SK; Peterson SR; Gupta A; Gibson-Corley KN; Mangalam AK
Sci Adv; 2021 Jul; 7(28):. PubMed ID: 34244137
[TBL] [Abstract][Full Text] [Related]
5. Does equol production determine soy endocrine effects?
Shor D; Sathyapalan T; Atkin SL; Thatcher NJ
Eur J Nutr; 2012 Jun; 51(4):389-98. PubMed ID: 22366740
[TBL] [Abstract][Full Text] [Related]
6. Dietary Isoflavones Alter Gut Microbiota and Lipopolysaccharide Biosynthesis to Reduce Inflammation.
Ghimire S; Cady NM; Lehman P; Peterson SR; Shahi SK; Rashid F; Giri S; Mangalam AK
Gut Microbes; 2022; 14(1):2127446. PubMed ID: 36179318
[TBL] [Abstract][Full Text] [Related]
7. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of soy isoflavone-glycosides in laying hens: intestinal absorption and preferential accumulation into egg yolk of equol, a more estrogenic metabolite of daidzein.
Saitoh S; Sato T; Harada H; Matsuda T
Biochim Biophys Acta; 2004 Sep; 1674(2):122-30. PubMed ID: 15374616
[TBL] [Abstract][Full Text] [Related]
9. Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.
Mayo B; Vázquez L; Flórez AB
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31527435
[TBL] [Abstract][Full Text] [Related]
10. Roles of Phytoestrogen in the Pathophysiology of Intracranial Aneurysm.
Yokosuka K; Rutledge C; Kamio Y; Kuwabara A; Sato H; Rahmani R; Purcell J; Eguchi S; Baranoski JF; Margaryan T; Tovmasyan A; Ai J; Lawton MT; Hashimoto T
Stroke; 2021 Aug; 52(8):2661-2670. PubMed ID: 34157864
[TBL] [Abstract][Full Text] [Related]
11. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women.
Xu X; Duncan AM; Merz BE; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1101-8. PubMed ID: 9865428
[TBL] [Abstract][Full Text] [Related]
12. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
[TBL] [Abstract][Full Text] [Related]
13. Is equol the key to the efficacy of soy foods?
Lampe JW
Am J Clin Nutr; 2009 May; 89(5):1664S-1667S. PubMed ID: 19357217
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women.
Leonard LM; Choi MS; Cross TL
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276910
[TBL] [Abstract][Full Text] [Related]
15. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
[TBL] [Abstract][Full Text] [Related]
16. Engineering
Kydd L; Shiveshwarkar P; Jaworski J
ACS Synth Biol; 2022 Nov; 11(11):3575-3582. PubMed ID: 36282591
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes.
Frankenfeld CL
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27470596
[TBL] [Abstract][Full Text] [Related]
19. Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics.
Haudum C; Lindheim L; Ascani A; Trummer C; Horvath A; Münzker J; Obermayer-Pietsch B
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32492805
[TBL] [Abstract][Full Text] [Related]
20. Phytoestrogen Metabolism by Adult Human Gut Microbiota.
Gaya P; Medina M; Sánchez-Jiménez A; Landete JM
Molecules; 2016 Aug; 21(8):. PubMed ID: 27517891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
